The Healthcare ETF Showdown: Broad Global Health or Targeted Pharma Power?

PJP delivered 32.8% returns over one year with concentrated U.S. pharma exposure, while IXJ offers broader global healthcare diversification and a higher…

1 sources · 1 articles · updated 2026-11-07 14:15 UTC · business

Coverage

1. The Healthcare ETF Showdown: Broad Global Health or Targeted Pharma Power?

   The Motley Fool · 2026-11-07 14:15 UTC

   PJP delivered 32.8% returns over one year with concentrated U.S. pharma exposure, while IXJ offers broader global healthcare diversification and a higher dividend yield.

   Summary on nerom.app